Get started

PHARMA

$TEVA - Weekly Chart 2020Teva's earnings May 7th - www.sec.gov Weekly chart is flashing buy signals with the 50SMA Crossing back under the price. Unknowns: COVID-19 impact on TEVA earnings Decision - Wait until after earnings to get in, still to many unknowns. The reason I like TEVA : Possible Turn-around play, looking for teva to turn net-loss to net-profit in the coming years if they continue to lower debt and start turning profit. Earnings (loss) per share attributable to ordinary shareholders: Basic ($) 2020 - Lower? 2019 - (0.91) even lower? 2018 - (2.35) Lower loss 2017 - (16.26) Huge loss 2016 - 0.07 Smaller profit 2015 - 1.84 Profit Diluted ($) 2019 - (0.91) 2018 - (2.35) 2017 - (16.26) 2016 - 0.07 2015 -1.82 www.sec.gov
NYSE:TEVALong
by AaronX
Easy Swing?GILD is moving with the news these days but the risk vs. reward is looking good, even after coming of the Double Top. I would love to see it bounce of the trend line and buy around $71 for a easy swing to an $80 target. Any good news can make this happen sooner than later. Regardless of the outcome of the trials, big pharma is one of the safest spots to invest right now in my opinion. Take this all with a grain of salt and do your own homework. I honestly have no idea what I'm talking about but just throwing up some ideas to look back at later.
NASDAQ:GILDLong
by lroman90
Another oversold pharma! Destiny Pharma (#DEST $DEST)See my chart for Oncimmune. Nice little bagger and similar conditions here. RSI just above 20. Historically, price has bounced when RSI has been between 12-20. Bought a tranche already and ready to buy more if it does slip further (possible depending on when/if results are released as that may let stale retail holders out). Price hovering on the lower BB bands so plenty of scope for recovery. Would have liked to seen the bands start narrowing but again another opportunity to buy more. Volume profile (weekly chart since IPO) about 44p. However, Phase 2B results due in H2, which, if successful, would be a major rerate catalyst and broker has a 250p target which is nice ramp fodder. Realistically, they'll need funding for Phase 3 (be it a placing or investment from a major). So happy to take a bag here and evaluate at the time whether to take a free ride or all the funds.
DLong
by AttilaTheKiller
NAVAMEDIC (NAVA) | Perfect Technically but Fundamentally So-So!Hi, Navamedic ASA, a MedTech and pharmaceutical company, in-licenses, buys and markets pharmaceuticals and other health care products in the Northern European region. Considering technical viewpoints then Navamedic has started to approach a pretty strong support area, a lot of criteria make up a strong crossing area. To be honest, I don't know much about Navamedic fundamentals but I can say, if you see some perspective in the future then this would be your perfect spot to buy it if you don't see then SKIP IT!! Technically a strong support area/buy-zone consists of: 1) A very strong resistance level becomes support. The price tried to break above the lower orange line 9(!) years and in the last year, it finally was successful. Now, this very strong resistance should act as a support level. 2) Inside the green buy-zone are also Monthly EMA50 and EMA100, plus Weekly EMA200 - all of them should act as support levels. 3) Fibonacci Golden ratio - Fibo retracement 62% 4) Navamedic becomes a member of a 50% club if the price reaches into the marked area. 5) Weekly timeframe AB=CD 6) Weekly timeframe channel projection It should be a pretty good spot to gain short-term profits, a perfect area should stay between 11.00-12.50 As said, do your own fundamental research and if this matching with my technical analysis viewpoints then you are ready to go! If it doesn't match then...skip it!! Regards, Vaido
OSL:NAVALong
by VaidoVeek
Speculative High-Return Idea - LONG "TEVA"I'm not gonna explain the fundamental data of the company for a long time, but I will say briefly that if you look at the dynamics of changes in the company's data, you can see a stable growth of the EPS indicators and a gradual moving towards a positive P&L. It is also indicative that with the huge fall of markets last week, the company did not “fly down” after the market. In the pharmaceutical sector, which itself is risky for investors, TEVA in recent months has shown good growth and the POTENTIAL for the long-term trend to transition from falling to rising. It has already broken up the resistance line lasting from the highest 2015 year point. However, the idea of ​​this post is no longer in long-term investment in this asset, but in speculative buying. The graph clearly shows the divergence of the asset price lows and its RSI and MACD indicators. According to Fibonacci, the stock adjusted to the desired level. Perhaps the fall to the level of 3703 Israeli Shekels and a rebound, or a rebound will be tomorrow. In any case, it is recommended to wait until the RSI fixes above 30 on the 1-hour chart, and then go into the idea. The way out of the idea is at least 4100 Shekels. Stop loss at your discretion, but 3650 is recommended. If you do not have access to the Israeli market, then do not be discouraged, paper is also listed in America under the same name TEVA P.S. It’s up to you to enter long-term or speculate, I recommend speculating only because I myself am a short-term speculator.
TASE:TEVALong
by Eminence-Grise
Pharma Stocks Don't move MuchWell for some reason the News is Killing the Market, I am down 60% Today, so decided to look at things with a different Light. Which ones Move differently depending on the Hype / News that is in our Ears. Got this one for $10 and next day it was $16 that might be the top for this one but Maybe not? I did not draw on the Chart but you can see it took off like a Rocket. There are Three Stocks that are dealing directly with Coronavirus this one was moderate price so I went with this guy. If it gets close to some of their previous levels could be interesting month. Just thought I would share. Have a good day and don't forget to Wash your Hands.
NASDAQ:NVAXShort
by Dudleydogg
3
CJJD On WatchChinese pharma play: - Move from 1.00 (May 24, '19) to recent $2.24 top (Jan 27, '20) and back to $1.73 today marks an approximate 50% retrace over the last 9 months - Currently in the heat of the Coronavirus battle; will likely show a bump in it's topline next quarterly report (July?) - Currently faces resistance at the baseline of the BB bands and 50MA which are both at $1.75 - Above its 200MA - 52 week high at $3.39 - Next stop is at $1.94 trendline, with support at $1.75 IF the price holds and is confirmed. - More support at 20MA ($1.71) and 9EMA ($1.67) - MACD looking ready for a crossover - KST at bottom of its range PT of $1.94 in the short term Back to $3.00 by July Stop Loss at $1.65 ------- Leave some feedback if you see things I can do better with my chart or if you have different ideas about what you see here in general! GLTA
NASDAQ:CJJDLong
by Blue_Collar_Trader
Nasdaq Healthcare: Closing on January 16thToday's session generated a bearish divergence on CCI. I am still bullish, but always ready for a trend retracement on the 20 EMA Line. Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal. I am not a financial advisor
NASDAQ:IXHCLong
by Investing_Fellow
Merck: Ichimoku Clouds on bullish setupIchimoku Clouds still confirm the bullish setup. Today's session will be important, if positive, to manifest further bullish intentions (Break of the $92.10 resistance). Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal. I am not a financial advisor.
NYSE:MRKLong
by Investing_Fellow
Nasdaq Healthcare: Closing on January 15thIf you like this idea, don't forget to support it clicking the Like Button! Positive session for Nasdaq Healthcare that gained 0.39%. However, I still see the possibility of a retracement over the basis of the Bollinger Bands indicator (orange crosses). I was waiting with anxiety today's session to check for a signal of retracement, and it comes with the third candles (17:00 - 19:00) The situation is also confirmed by RSI and CCI indicators. Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal. I am not a financial advisor
NASDAQ:IXHCLong
by Investing_Fellow